US Stock MarketDetailed Quotes

ALT Altimmune

Watchlist
  • 7.900
  • +0.220+2.86%
Close Jul 12 16:00 ET
  • 7.900
  • 0.0000.00%
Post 19:43 ET
560.13MMarket Cap-4937P/E (TTM)

Altimmune Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Altimmune Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

5.00K

-76.19%
EPS(YoY)

-0.34

+15.00%
Analyst Rating

Strong Buy

Jul 13, 2024

Altimmune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 31.251M--
--2024/Q2-- / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--
Nov 7, 20232023/Q3362.000K / 860.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 31.251M--
--2024/Q2-- / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--
Nov 7, 20232023/Q3362.000K / 860.000--

Unlock Free Earnings Estimates

Altimmune Earnings Reports

  • Altimmune | 10-Q: Quarterly report

    May 9 17:13 ET

  • Altimmune | 10-K: Annual report

    Mar 27 16:05 ET

  • Altimmune: Q3 2023 Earnings Report

    Nov 7, 2023 16:08 ET

  • Altimmune | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 13, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday+1.52%